Vitamin D Homeostasis in Sarcoidosis
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age21+
SponsorUniversity of Texas Southwestern Medical Center
About this trial
This study evaluates the relationship between vitamin-D status and severity of sarcoidosis, and the effects of vitamin-D repletion in vitamin-D insufficient patients with sarcoidosis. Half the patients with sarcoidosis who are vitamin-D insufficient will receive standard vitamin-D supplementation via standard regimen while the other half will receive a placebo. Sarcoidosis patients who are vitamin-D sufficient will also act as controls.
Eligibility criteria
Qualifiers
Stable medical condition defined as no hospitalization or emergency room visit in the previous 3 months
No evidence of active pulmonary or systemic infection
No other active inflammatory disease,
No active malignancy.
Disqualifiers
Hospitalization or emergency room visit in the previous 3 months
Evidence of active pulmonary or systemic infection
Evidence of active other inflammatory disease
Evidence of active malignancy
Trial design
Treatments tested in this trial
- Ergocalciferol
- Placebo
- Calcium Citrate with Vitamin D2
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov